Tower Research Capital LLC (Trc) Pet Vivo Holdings, Inc. Transaction History

Tower Research Capital LLC (Trc)

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.99 - $1.46 $1,511 - $2,229	1,527 Added 40.28%	5,318 $5,000
Q4 2023 Feb 13, 2024	BUY	$0.6 - $2.18 $1,368 - $4,970	2,280 Added 150.89%	3,791 $4,000
Q3 2023 Nov 14, 2023	SELL	$1.72 - $2.45 $3,061 - $4,361	-1,780 Reduced 54.09%	1,511 $2,000
Q2 2023 Aug 14, 2023	SELL	$1.89 - $2.92 $578 - $893	-306 Reduced 8.51%	3,291 $6,000
Q1 2023 May 09, 2023	SELL	$2.2 - $3.4 $3,187 - $4,926	-1,449 Reduced 28.72%	3,597 $10,000
Q4 2022 Feb 10, 2023	BUY	$1.85 - $2.69 $1,515 - $2,203	819 Added 19.38%	5,046 $10,000
Q3 2022 Nov 10, 2022	BUY	$0.28 - $2.89 $683 - $7,054	2,441 Added 136.67%	4,227 $8,000
Q2 2022 Aug 15, 2022	BUY	$1.3 - $2.63 $2,173 - $4,397	1,672 Added 1466.67%	1,786 $3,000
Q1 2022 May 12, 2022	BUY	$1.25 - $3.97 $142 - $452	114 New	114 $0
Q4 2021 Feb 14, 2022	SELL	$2.4 - $5.01 $561 - $1,172	-234 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.62 - $9.25 $613 - $2,164	234 New	234 $1,000

Ticker PETV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,072,000
Market Cap $5.04M
Description
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint affliction...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.